XORTX Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$2,859,371 over the previous period. Total operating expenses were $4,805,077.
Profit Margin
| 2015 | 0 | -36.92K | |
|---|---|---|---|
| 2016 | 0 | -414.83K | |
| 2017 | 0 | -474.20K | |
| 2018 | 0 | -3.77M | |
| 2019 | 0 | -629.57K | |
| 2020 | 0 | -1.28M | |
| 2021 | 0 | -1.29M | |
| 2022 | 0 | -6.98M | |
| 2023 | 0 | -2.85M |
XRTX.V Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 141.95K | 75.26K | 17.88K | 20.43K | 19.9K | 0 | 0 | 0 | 0 |
Gross profit | -141.95K | -75.26K | -17.88K | -20.43K | -19.9K | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 2.41M | 6.48M | 669.10K | 277.45K | 39.89K | 342.25K | 66.36K | 0 | 0 |
Selling and marketing | 1.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 4.80M | 9.86M | 2.86M | 1.30M | 565.96K | 1.15M | 464.06K | 405.33K | 36.92K |
Operating income | -4.80M | -10.68M | -4.13M | -1.30M | -565.96K | -1.15M | -469.44K | -405.33K | -36.92K |
Other income (expenses), net | 1.94M | 3.69M | 2.84M | -202.36K | -26.39K | -2.59M | -47.09K | -870 | 0 |
Income before tax | -2.85M | -6.98M | -1.29M | -1.28M | -629.57K | -3.77M | -474.20K | -414.83K | -36.92K |
Income tax expense | 0 | 9 | 4.39K | 13.51K | 37.21K | 22.29K | 10.08K | 8.62K | 0 |
Net income | -2.85M | -6.98M | -1.29M | -1.28M | -629.57K | -3.77M | -474.20K | -414.83K | -36.92K |
Earnings per share | |||||||||
Basic EPS | -1.44 | -4.72 | -1.19 | -1.73 | -1.06 | -6.45 | -2.24 | -2.05 | -0.49 |
Diluted EPS | -1.44 | -4.72 | -1.19 | -1.73 | -1.06 | -6.45 | -2.24 | -2.05 | -0.49 |